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Exposure of neonatal mice to antigen often results in Th2-biased responses in later life. Examples of
this Th2 tendency are (a) secondary antibody responses dominated by the Th2-associated IgG1 isotype
and (b) Th2-mediated tolerance to alloantigens. We previously reported that neonates develop primary
Th1 and Th2 function in the lymph nodes but exclusive Th2 primary splenic responses. Here, we have
tested whether the Th2 bias of adults initially immunized as neonates is due to the early, primary Th2
polarization in the spleen. Surprisingly, removal of the spleen at birth had no affect on either IgG1-
dominant secondary responses or the development of tolerance to alloantigens. Thus, neonatal lymph
nodesaresufﬁcienttogenerateTh2-biasedfunctionfollowingneonatalantigenexposure.Tounderstand
how this could arise, we examined the primary Th1/Th2 responses of CD4
þ lymph node cells. Unlike
the balanced Th1/Th2 responses seen with total lymph node cells, the primary responses of isolated
CD4
þ cells were skewed to IL-4 producing function. These results suggest that the early development
of Th2-dominant responses by lymph node CD4
þ cells contributes substantially to the subsequent
development of Th2-dominant memory in neonates.
Keywords: Ontogeny(neonatal); Th1/Th2; Memory; Tolerance; Spleen and lymph nodes
INTRODUCTION
CD4
þ T helper (Th) cells can be functionally divided into
Th1 and Th2 subsets (Mosmann and Coffman, 1989;
Swain et al., 1991; Abbas et al., 1996). The Th1 subset
produces -IFN and mediates delayed-type hypersensitivity
and protection against intracellular pathogens. The Th2
subset produces IL-4 and IL-5 and is important in humoral
responses. Immune responses heavily skewed toward Th1
or Th2 function can exacerbate infectious diseases,
allergic reactions and autoimmunity. Thus, generating
and maintaining the appropriate Th1/Th2 balance is
critical for protective immunity. This is especially
important for the very early stages of life, when exposure
to many novel antigens occurs.
Over the last decade, it has become increasingly clear
that murine neonates are immature in the development of
Th function. In particular, murine neonates are prone to
Th2 responses (reviewed in Adkins (2000)), Garcia et al.
(2000) and Siegrist (2000). Notably, a single exposure
to antigen during the neonatal period often leads to
Th2 dominant memory responses much later in life,
once the animals have grown to adulthood and are
subsequently re-exposed to the same antigen. Well
characterized examples of this Th2 bias are seen in the
secondary responses to protein antigen immunization
and in the maintenance of Th2-mediated tolerance
to alloantigens.
The Th2biased memory responses of animals originally
immunized as neonates with protein antigen are clearly
systemic. For example, memory effector cells from both
the lymph nodes and spleens show preferential Th2
cytokine production when restimulated with the antigen
in vitro (Barrios et al., 1996; Adkins and Du, 1998).
Moreover, neonates injected i.p. or i.v. with allogeneic
cells subsequently reject, in a Th2-dependent manner,
donor origin skin grafts transplanted to the tail in later
adult life (Goldman et al., 1989; Schurmans et al., 1990;
Chen et al., 1995; Donckier et al., 1995; Gao et al., 1996).
How these Th2 dominant responses originally arise is, at
present, unclear. One possibility is that the Th1/Th2
pattern of memory cell generation is set early, during the
primary response phase. For example, if neonates
preferentially mounted Th2 primary responses initially,
this might lead to relatively greater Th2 memory cell
formation. In investigations of the primary responses of
neonates, we have recently shown (Adkins et al., 2000)
that the responses that develop in the ﬁrst week of life are
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While lymph node cells developed a mixed Th1/Th2
primary response to protein antigen immunization,
neonatal spleens showed exclusive primary Th2 function.
In this report, we have addressed the hypothesis that the
Th2-dominant primary responses in the neonatal spleen
lead to the systemic Th2 dominant memory responses in
later adult life. Spleens were surgically resected on day 1
of life and subsequent Th1/Th2 memory responses were
monitored. As assessed by serum IgG responses and
tolerance to skin allografts, quantitatively and qualitat-
ively similar Th2-biased memory responses developed in
the presence or absence of the spleen. Thus, the lymph
node responses alone are sufﬁcient to generate the
secondary Th2 bias associated with neonatal exposure to
antigen. Further analyses demonstrated that, while total
lymph node cells developed balanced Th1/Th2 function in
response to primary immunization, the primary responses
of CD4
þ cells were skewed to the Th2 lineage. These
results indicate that the preferential development of
primary Th2 effector function in the neonatal lymph node
CD4
þ population contributes substantially to the Th2
biased secondary responses of neonates.
RESULTS
The Neonatal Spleen is Not Required for the
Development of Secondary Serum IgG Responses
Dominated by the Th2-associated IgG1 Isotype
In an earlier study (Adkins et al., 2001), we investigated
the role of the neonatal spleen in the secondary cytokine
recall responses of neonatal Tcells.We found that animals
splenectomized and immunized at birth developed Th2
dominant memory responses that were qualitatively and
quantitatively similar to those produced by normal
littermates. Those results suggested that the neonatal
spleen is not required for the generation of Th2 dominant
secondary responses. However, the possibility remained
that the pattern of cytokines produced in vitro may not
accurately reﬂect the levels of Th1/Th2 cytokines
available in vivo. To address this issue, we chose to
examine the relative levels of Th1- vs. Th2-associated IgG
isotypes produced in vivo in response to T cell dependent
antigen immunization. One day old or adult BALB/c mice
were splenectomized and immunized with DNP-KLH in
PBS. Normal, unmanipulated animals of each age group
were immunized in parallel. Two weeks later, the animals
were reimmunized with DNP-KLH in PBS. After an
additional 2 weeks, sera were prepared and anti-DNP
IgG2a (Th1-associated) and IgG1 (Th2-associated)
levels were measured by speciﬁc ELISA (Fig. 1).
As previously reported (Adkins and Du, 1998), the titers
of secondary anti-DNP speciﬁc IgG1 antibodies were
similar in normal neonates and adults while neonates
produced markedly less speciﬁc IgG2a. This pattern was
unaltered by splenectomy, either in neonates or adults.
Thus, the neonatal lymph node response alone is sufﬁcient
to produce secondary responses dominated by the Th2-
associated isotype IgG1.
Neonatal Lymph Nodes are Sufﬁcient to Generate
and Maintain Th2-mediated Tolerance to Alloantigens
as well as Tolerance to Peripheral Tissue Antigens
One of the unique hallmarks of the neonatal period is the
capacity to become tolerant to allogeneic cells (Bill-
ingham et al., 1953). It has been shown that IL-4
production in vivo is necessary for the induction and
maintenance of neonatally induced tolerance to semiallo-
geneic F1 cells (Schurmans et al., 1990; Donckier et al.,
1995; Gao et al., 1996). Thus, we next tested whether the
splenic Th2 dominant responses are required for
the induction of tolerance to alloantigens. Four groups
of 1-day-old BALB/c neonates were created. Group 1 was
left completely unmanipulated (normals). The neonates in
group 2 were splenectomized (spx). Group 3 animals were
FIGURE 1 Removal of the spleen at birth does not diminish the
dominance of the Th2-associated IgG1 isotype following secondary
immunization. One day old or adult BALB/c mice were splenectomized
and immunized with DNP-KLH in PBS. Normal, age-matched animals
were also immunized in parallel. Two weeks later, all animals were
reimmunized with DNP-KLH in PBS. Following an additional 2 weeks,
sera were prepared and the levels of anti-DNP IgG2a and IgG1 were
determined by speciﬁc ELISA. Each line represents an individual animal.
Numbers of animals examined were as follows: normal neonates, 2;
normal adults, 2; splenectomized (spx) neonates, 4; splenectomized
adults, 2. All animals are shown; in some cases, it is not possible to
distinguish individual normal animals (open circles) because their lines
are superimposed with the closed circles. Each point is the average
O.D. ^ standard deviation of three replicate samples. Where error bars
do not appear, the size of the error was smaller than the size of the
symbol.
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from adult CAF1 mice (normal þ CAF1). Group 4
animals were splenectomized and injected with adult
CAF1 cells (spx þ CAF1). Four weeks later, all animals
received skin grafts from donor-type CAF1 mice or from
third party, unrelated C57BL/6 mice. The survival of the
grafts was then recorded daily, out to 42 days post grafting
(Table I). All animals, regardless of their treatment during
neonatal life, rejected the third party C57BL/6 skin grafts
within similar time spans. Animals splenectomized as
neonates rejected CAF1 grafts as readily as their normal
littermates. Surprisingly, the absence of the spleen had no
effect on the capacity of neonates to become tolerant to
CAF1 cells. While 1 of 4 mice in the normal group that
received CAF1 cells at birth actually rejected the CAF1
graft, all of the seven splenectomized neonates that
received CAF1 cells at birth retained their grafts for 42
days, with no signs of rejection. Thus, the responses
generated in the neonatal lymph nodes alone are sufﬁcient
to establish and maintain neonatal tolerance to
alloantigens.
In normal neonates, Th2 responses have been shown
to dominate in this transplantation model (Goldman
et al., 1989; Schurmans et al., 1990; Chen et al., 1995;
Donckier et al., 1995; Gao et al., 1996). To determine
whether exclusive Th2 responses also developed in the
absence of the spleen, the Th1/Th2 recall responses of
lymph node cells from the same animals were
monitored in vitro 49 days after the initial skin
grafting. As expected from the normal rejection of the
C57BL/6 skin grafts, all groups mounted a robust and
exclusive Th1 response to C57BL/6 splenocytes (Fig.
2). Both the normal and the splenectomy groups also
produced high levels of -IFN but no IL-4 in response to
restimulation with CAF1 cells. These results are
expected since these animals were not exposed to
CAF1 or C57BL/6 cells as neonates but were primed as
adults to CAF1 and C57BL/6 antigens via the skin
grafts. For all of the normal animals that received CAF1
cells at birth, IFN production in response to CAF1 cells
was low to undetectable. Two of the four animals in
this group produced high levels of IL-4 while IL-4 was
undetectable in the other two. Similarly, in the group
that was splenectomized and exposed to CAF1 cells at
birth, 3 of the 7 animals produced high levels of IL-4 in
response to CAF1 cells. However, unlike in the
corresponding normal group, two of the animals in
this group also made high levels of IFN. These results
suggest that secondary responses arising in asplenic
neonates may not always be exclusively Th2 but may
instead be mixed Th1/Th2, similar to the primary
responses seen in neonatal lymph nodes. Nonetheless,
because these animals all became tolerant to CAF1
cells, as evidenced by acceptance of CAF1 skin grafts,
the Th2 response (or no response) must be dominant
in vivo.
While tolerance to injected alloantigens does not appear
to require the spleen, it seemed possible that other forms
of tolerance that must be established in early life may
require the neonatal spleen. Notably, in neonates, a large
number of newly generated T cells are encountering
peripheral tissue antigens for the ﬁrst time. Tolerance to
these antigens must be established in the periphery to
ensure that autoimmunity does not develop. Since T cell
mediated autoimmunity is often a Th1-associated
phenomenon (Liblau et al., 1995), it could be postulated
that the Th2 dominant responses of the neonatal spleen act
to suppress Th1 activity and hence, help to avoid
autoimmune reactions. A clear prediction of this
hypothesis is that removal of the early splenic Th2
responses would lead to autoimmune reactions to cells or
organs in the periphery. This idea was tested by assessing
the potential for the development of autoreactivity in
splenectomized neonates. Control and splenectomized
neonates were allowed to grow to 6 months of age. At that
time, major organs that are common targets in
autoimmune disease were examined histologically for
gross signs of tissue pathology. The pancreas, stomachs,
thyroids, kidneys, adrenals, thymus, colons and testes
and ovaries of the splenectomized mice were indis-
tinguishable from those of the control normal mice (data
not shown). Moreover, the sera from the splenectomized
mice did not contain elevated levels of autoantibodies
commonly found in autoimmune disease (Fig. 3).
TABLE I The spleen is not required for the generation of tolerance to alloantigens in neonates
Group* Skin graft Number of rejected/number of transplanted Mean day of rejection
Normal CAF1 7/7 14.3 ^ 3.1
Spx CAF1 8/8 18.9 ^ 2.0
Normal þ CAF1 CAF1 1/4 Not applicable
Spx þ CAF1 CAF1 0/7 Not applicable
Normal C57BL/6 7/7 14.0 ^ 3.3
Spx C57BL/6 8/8 18.3 ^ 2.1
Normal þ CAF1 C57BL/6 4/4 17.6 ^ 3.2
Spx þ CAF1 C57BL/6 7/7 16.9 ^ 2.9
*One group of 1 day old BALB/c mice was splenectomized (spx); another group was not splenectomized. Each of these two groups was divided into two groups; one set
received 1 £ 107 CAF1 spleen plus lymph node cells i.v. the other set received no cells. Four weeks later, all animals were transplanted with skin grafts from CAF1 or
C57BL/6 mice. The survival of the skin grafts was subsequently monitored for 42 days.
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neonates are sufﬁcient to establish peripheral tolerance to
tissue antigens in early life.
Balanced Frequencies of Primary IL-4: IFN Secreting
Cells among Total Neonatal Lymph Node Cells but Th2
Skewing among the CD4
1 Population
The previous experiments clearly demonstrated that
neonates develop Th2 skewed secondary responses, even
in the absence of the Th2 dominant primary responses of
the spleen. For Th2 dominant memory responses to
become established in neonates, the evidence suggests that
Th2 responses must dominate early, at least in the
allogeneic tolerance model we have used (Schurmans
et al., 1990; Donckier et al., 1995; Gao et al., 1996).
Together with our splenectomy experiments, this would
suggest that Th2 dominance must be established during
primary responses in the lymph nodes. However, in earlier
studies (Adkins and Du, 1998), we had found that primary
lymph node responses were not Th2 skewed, showing
instead the same relative production of Th1/Th2 cytokines
as in adult lymph nodes. In these earlier experiments,
we used ELISA assays, which measure the total amount
of cytokine produced in bulk cultures in vitro. We next
considered the possibility that Th2 dominance
in the neonatal lymph nodes may be achieved by
the development of greater numbers of primary Th2
compared to Th1 cells. To test this possibility, we used
ELISPOT assays to measure the frequencies of primary -
IFN- or IL-4 secreting cells in neonatal vs. adult lymph
nodes. One day old or adult BALB/c mice were
immunized with KLH in PBS and the frequencies of
IFN- or IL-4-secreting cells were determined 1 week later
by ELISPOT (Table II). Greater frequencies (2–8 fold
higher; p , 0:001 within each experiment) of both IFN-
and IL-4-producing cells developed in neonatal compared
to adult lymph nodes. Nonetheless, consistent with our
earlier ELISA data (Adkins and Du, 1998), the ratios of
IL-4: IFN-secreting cells among neonatal cells were not
signiﬁcantly different from those of adult cells (Table II).
The secondary responses we have analyzed, serum IgG
memory responses and alloantigen tolerance, are both
mediated by CD4
þ cells. Therefore, wewished to examine
further the primary responses in the lymph nodes by
investigating the functions of isolated CD4
þ cells. One
day old or adult BALB/c mice were immunized with KLH
in PBS. One week later, lymph node CD4
þ cells were
prepared, re-stimulated with KLH in the presence of
adult splenic APC, and assessed for the frequencies
of IFN- or IL-4-secreting cells by ELISPOT (Fig. 4).
Similar frequencies of IFN-secreting cells were seen
among CD4
þ cells from neonatal and adult lymph nodes.
In contrast, signiﬁcantly greater ðp , 0:001Þ frequencies
FIGURE 2 Th1/Th2 cytokine production by normal and splenectomized animals injected at birth with semiallogeneic F1 cells. Four groups of 1 day
old BALB/c neonates were analyzed. Group 1 was unmanipulated (normals). Neonates in group 2 were splenectomized (spx). Group 3 neonates were
injected i.v. with 1 £ 107 spleen and lymph node cells from adult CAF1 mice (normal þ CAF1). Group 4 neonates were splenectomized and injected
with adult CAF1 cells (spx þ CAF1). Four weeks later, all animals received skin grafts from donor-type CAF1 mice or from third party, unrelated
C57BL/6 mice. Forty-nine days later, lymph node cells were restimulated with mitomycin treated splenocytes from syngeneic BALB/c mice or from
CAF1 or C57BL/6 mice. Supernatants were tested for IFN (48h supernatants) or IL-4 (72h supernatants) content by speciﬁc ELISA. Each symbol
represents an individual animal. The numbers of animals in each group were as follows: normal, 7; spx, 8; normal þ CAF1, 4; spx þ CAF1, 7. Each
point is the average ^ standard deviation from triplicate samples. Where error bars do not appear, the size of the error was smaller than the size of the
symbol.
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þ cells from
neonates, compared to adult CD4
þ cells. Thus, there is
clear Th2-skewing among neonatal CD4
þ cells in the
primary response to protein antigen immunization.
To ensure that Th2-skewed primary responses among
neonatal CD4
þ cells were not limited to protein antigens,
primary responses to alloantigen immunization were
similarly examined. One day old neonatal or adult
BALB/c mice were injected with 1 £ 107 spleen and
lymph node cells from adult CAF1 mice. Parallel, aged
matched mice that did not receive any cells served as
control, non-primed mice. One week later, CD4
þ cells
were prepared from lymph nodes and restimulated with
mitomycin C treated CAF1 spleen cells. The IFN and IL-4
contents of the supernatants were analyzed by ELISA
(Fig. 5). IFN was readily detected in the supernatants from
both the neonatal and adult cultures; neonatal CD4
þ
lymph node cells made approximately 2-fold less IFN
than did adult cells. High levels of IL-4 were also secreted
by neonatal CD4
þ cells. In contrast, IL-4 was undetect-
able in the adult CD4
þ cell cultures. Thus, similar to
what was observed with protein antigen immunization,
neonatal CD4
þ cells developed a mixed Th1/Th2
primary response to alloantigen immunization and
the neonatal response was clearly Th2-skewed, compared
to the adult response.
To test whether neonatal APC function was important in
regulating Th2-skewed responses, the invitro responses of
isolated neonatal CD4
þ cells were examined. CD4
þ cells
were prepared from unprimed 7-day-old or adult BALB/c
mice and stimulated in culture with mitomycin C treated
splenocytes from either fully allogeneic (C57BL/6) or
semi-allogeneic (CAF1) adult mice. Supernatents were
harvested at 24, 48 and 72h of culture and the secreted
cytokines were measured by ELISA (Fig. 6). In both
FIGURE 4 Th2-skewed CD4
þ primary responses develop in neonatal
lymph nodes in response to protein antigen immunization. One day old or
adult BALB/c mice were immunized with KLH in PBS. One week later,
CD4
þcells were prepared from lymph nodes and restimulated with KLH
in the presence of adult splenic APC. After 48h, the cells were processed
by ELISPOT methods to determine the frequencies of IFN- or IL-4-
secreting cells. One experiment typical of two separate experiments for
each responding cell type is shown. The frequencies of cytokine-
secreting cells (y axis) are per 10
6 CD4
þ cells.
FIGURE 3 Removal of the spleen at birth does not result in increased
incidence of autoantibody production. One day old BALB/c mice were
left unmanipulated (normal) or splenectomized (spx). Six months later,
sera were prepared and tested for anti-nuclear antibodies using
commercially purchased ELISA kits, according to the manufacturer’s
directions. The speciﬁc absorbance was calculated as the absorbance
values obtained with samples placed in antigen-coated wells minus the
absorbance values obtained with samples placed in non-coated wells.
Positive and negative controls were provided by the manufacturer.
The numbers of animals were as follows: normal, 7; splenectomized, 7.
Each point is the average ^ standard deviation from triplicate samples of
individual animals.
TABLE II Higher frequencies of both IFN- or IL-4-secreting cells
develop in neonatal, compared to adult lymph nodes, in response to
primary immunization
Per 10
6 total lymph node cells*
IFN
secretors
IL-4
secretors
Ratio of IL-4:
IFN secretors
Exp 1
Neo 773.3 ^ 111.5 3,462.7 ^ 360.7 4.48
Adult 125.8 ^ 10.1 450.0 ^ 40.1 3.58
Exp 2
Neo 1,128.8 ^ 133.0 4,618.4 ^ 563.7 4.09
Adult 660.0 ^ 14.1 1,677.5 ^ 242.7 2.54
Exp 3
Neo 1,983.3 ^ 76.5 6,416.7 ^ 58.9 3.24
Adult 790.0 ^ 50.0 2,018.8 ^ 106.1 2.56
Exp 4
Neo 1,017.1 ^ 0.6 2,446.1 ^ 108.3 2.40
Adult 236.0 ^ 10.6 1,187.1 ^ 58.6 5.03
*One day old or adult BALB/c mice were immunized with KLH in PBS. One week
later, total lymph node cells were prepared and assayed by ELISPOT analyses for
the frequencies of KLH speciﬁc, IFN- or IL-4-secreting cells. Frequencies are
averages ^ standard deviations from four replicate samples.
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þ cells demonstrated Th2-skewed
responses, with patterns of cytokine production similar to
those that developed in vivo. Thus, the development of
Th2-biased primary responses does not appear to require
neonatal APC. Together, these results indicate that lymph
node CD4
þ cells in neonates develop Th2 biased primary
responses; these biased primary responses may contribute
substantially to the Th2-skewed secondary responses
observed both in normal and splenectomized neonates.
DISCUSSION
We have addressed the hypothesis that the exclusive Th2
primary responses that develop in the neonatal spleen are
responsible for the Th2-biased secondary responses often
seen in neonates. Two experimental systems in which
Th2-skewing occurs in response to neonatal antigen
exposure were used: (a) protein immunization leading to
secondary antibody responses dominated by the Th2
isotype IgG1 and (b) the injection of allogeneic cells
resulting in Th2-mediated tolerance to alloantigens. These
responses were compared in normal neonates and in
neonates in which the spleen was removed at birth.
Surprisingly, the absence of the spleen had no effect on
these responses; splenectomized neonates were equivalent
to their normal littermates in the development of
secondary IgG1-dominant serum responses and tolerance
to alloantigens. In addition, the neonatal period is
characterized by the natural establishment of tolerance
to self-antigens found in peripheral organs. Histological
and serum autoantibody screening showed that removal of
the spleen at birth also did not increase the incidence of
autoimmunity. Thus, responses occurring in the neonatal
lymph nodes alone are sufﬁcient to establish Th2 skewed
secondary responses to protein antigen immunization as
well as tolerance to allo- and self-antigens. To understand
how Th2 skewed secondary responses become
FIGURE 5 Neonatal lymph node CD4
þ cells develop Th2-skewed
primaryfunction invivo in response to alloantigenexposure. One day old
or adult BALB/c mice were injected i.v. with 1 £ 107 spleen and lymph
node cells from adult CAF1 mice. Age-matched control mice did not
receive any cells. One week later, CD4
þ lymph node cells were prepared
and stimulated with mitomycin C treated CAF1 splenocytes.
Supernatants were harvested 48h later and IFN and IL-4 content were
measured by speciﬁc ELISA. One experiment representative of two
independent experiments is shown.
FIGURE 6 Neonatal lymph node CD4
þ cells develop Th2-skewed primary function in vitro, in the absence of neonatal APC. CD4
þ
cells were prepared from lymph nodes of 7 day old or adult unprimed BALB/c mice. The cells were cocultured with mitomycin C treated
splenocytes from C57BL/6 (a) or CAF1 (b) adult mice. Supernatants were collected at 24, 48 and 72h cytokine content was analyzed by speciﬁc
ELISA.
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secreting cells developing during primary responses in
neonatal lymph nodes. ELISPOT analyses revealed that
signiﬁcantly greater frequencies of both IFN- and IL-4-
secreting cells developed among total neonatal, compared
to adult, lymph node cells. Greater frequencies of IL-4-
producing cells also developed among isolated CD4
þ
neonatal cells, compared to adult CD4
þ cells. In contrast,
CD4
þ neonatal cells developed frequencies of IFN-
secreting cells similar to those found among the CD4
þ
adult population. As a result, while total lymph node cells
in neonates and adults showed similar ratios of IL-4: IFN
secretors, this ratio for neonatal CD4
þ population was
skewed to IL-4 production.
One striking observation in these experiments is that the
absolute amounts of secondary serum antibodies appear to
be similar in normal and splenectomized neonates. Since
the lymph nodes are the only site of B cell memory
development in splenectomized neonates, the lymph
nodes may then also be the major site of B cell memory
formation in intact neonates. B cell memory development
is promoted by primary CD4
þ cells that home to germinal
centers (reviewed in MacLennan (1994), Przylepa et al.
(1998) and Tarlinton (1998)). Therefore, the production of
Th2-skewed B cell memoryresponses, even in the absence
of the spleen, is consistent with the development of
primary lymph node CD4
þ responses that are Th2-biased.
We previously reported (Adkins and Du, 1998) that,
although secondary B cell responses are Th2-biased,
neonates and adults generate similar ratios of the IgG2a
(Th1-associated) and IgG1 (Th2-associated) isotypes in
primary serum responses. If primary CD4
þ responses are
Th2-skewed, how do primary serum IgG2a/IgG1
responses that are adult-like arise? One possibility is
that, unlike in germinal centers, non-CD4
þ cells may
provide a more balanced (or even Th1-skewed) source of
cytokines for usage by primary B cell antibody forming
cells in the T cell zones. Thus, we are examining the
Tc1/Tc2 responses of neonatal CD8
þ cells to determine
whether CD8
þ cells might provide more balanced
levels of IFN/IL-4 during primary responses in neonatal
lymph nodes.
In earlier studies (Adkins et al., 2000), we showed that
primary effector responses arising in the neonatal spleen
were exclusively Th2-like. This report establishes that the
primary responses among neonatal lymph node CD4
þ
cells, while not exclusively Th2, are biased to the Th2
lineage. How could this arise? In adults, it is generally
believed that the major factors controlling Th1 vs. Th2
development are the environmental signals (cytokines,
costimulation) present atthe time of initial priming (Swain
et al., 1991; Seder and Paul, 1994; Abbas et al., 1996;
O’Garra, 1998; Moser and Murphy, 2000). Thus, signals
coming from the APC compartment or other cell types
may result in Th2 skewed development in neonates.
Some recent evidence is consistent with this possibility.
For example, reduced expression of class II MHC and
costimulatory molecules have been reported for murine
neonatal dendritic cells, B cells and monocytes (Goriely
et al., 2001; Muthukkumar et al., 2002). Diminished
production of the Th1 promoting cytokine IL-12 by
neonatalmonocyteshasalsobeendescribed(Gorielyetal.,
2001). In contrast to those reports, however, phenotypi-
cally mature dendritic cells capable of promoting vigorous
CTL responses (and presumably strong Th1 responses)
have recently been isolated from the neonatal spleen,
albeit in reduced numbers (Dadaglio et al., 2002). Thus, at
this point, the contribution of APC function to neonatal
Th2 skewing is unclear. Another possibility is that
intrinsic properties of the T cells themselves are a factor in
neonatal Th2 skewing. Our data showing that Th2-
skewing develops in vitro, in the presence of adult APC
(Fig.6), is consistent with this idea. Moreover,we recently
reported (Adkins et al., 2002) that intrinsic properties of
neonatal T cells contribute to Th2-skewing in vivo;
in adoptive adult hosts, neonatal lymph node CD4
þ cells
were highly deﬁcient in the development of Th1 function.
How might these functional differences between neonatal
and adult CD4
þ cells arise? There is at least one clear way
inwhich naiveneonatalandadultTcellpopulations differ.
In the adult, only a very small percentage of peripheral
Tcellsarerecentlyemigratedfromthethymus.Incontrast,
the vast majority of peripheral T cells in neonates are new
thymicemigrants.Infact,the primaryeffectorfunctionsof
lymph node CD4
þ cells in neonates look remarkably
similar to those of recent thymic migrants in adults.
In particular, mixed Th1/Th2 responses are elicited but,
compared to resident peripheral adult T cells, the
responses of recent migrants are Th2-skewed (Bendelac
et al., 1992). We are in the process of directly testing the
idea that neonatal T cell Th function results from their
recent migration from the thymus.
The experiments here as well as those reported earlier
(Adkinsetal.,2001)clearlyshowthattheneonatalspleenis
not required for many of the Th2-mediated functions
associated with neonatal antigen exposure. Why neonatal
primary splenic responses would be so Th2-biased is still a
mystery. One possibility is that the neonatal splenic Th2
responses are only a part of the machinery necessary
for generating, e.g. tolerance to allo- or self-antigens.
In the absence of the spleen, other mechanisms
(e.g.regulatorycells)maycompensatetogeneratetolerance.
If this is so, it may not be possible to see a major
effect of eliminating the splenic responses. It may, how-
ever, be possible to see an augmentation or acceleration of
oneoftheseprocesses.Forexample,inacasewhereanimals
develop juvenile onset, Th1-mediated autoimmune disease,
as in NOD mice (Yoshida and Kikutani, 2002), removal of
the spleen may exacerbate the disease or accelerate disease
onset. We are currently considering examining the effect of
neonatal splenectomy in autoimmune disease models, such
as the NOD mice.
Studies from the laboratory of M. Goldman (Donckier
et al., 1995) showed that IL-4 RNA is upregulated in
neonatallymphnodesasearlyas2daysaftertheinjectionof
allogeneic cells. Our results, examining the responses of
NEONATAL LYMPH NODES AND TH2 MEMORY 49lymph node cells one week after the injection of allogeneic
cells,conﬁrmthis resultandextenditintwoways. First,we
have shown that high levels of IL-4 protein are made by
neonatal,butnotadult,CD4
þlymphnodecells.Second,we
demonstrate that, in the primary response phase, signiﬁcant
alloantigen-speciﬁc Th1 activity also develops. However,
this primary Th1 function is apparently not converted to or
maintained as memory very efﬁciently because, in normal
neonates,littletonoIFNisproducedbyalloantigen-speciﬁc
memorycells.Howthisoccursisunclearbutweknowfrom
in vitro experiments that neonatal T cells are more
susceptible to apoptosis than adult T cells (Adkins et al.,
1996). Thus, it is tempting to speculate that the Th1 cells
arisinginneonatesaremoresusceptiblethantheTh2cellsto
apoptotis induction.
MATERIALS AND METHODS
Mice
BALB/c mice, originally obtained from Charles River
Laboratories (Wilmington, MA), were bred and
housed under barrier conditions in the Division of
Veterinary Resources at the University of Miami Medical
School. Periodic screening showed the colony to be free of
commonlyoccuringinfectiousagents.Femalesfromtimed
matings were monitored closely from days 19–21 of
gestation and the date of delivery recorded. Birth day was
called day 0. Neonatal animals were deﬁned as 1 day old.
C57BL/6 and (BALB/c £ A/J)F1 mice, referred to as
CAF1 mice, were purchased from Jackson Laboratories
(Bar Harbor, ME). Adult (.6 weeks old) mice of these
strains were used for donor cells and skin.
Protein Antigen Immunization
One day old neonatal or adult (6–10 weeks old) BALB/c
mice were immunized with, respectively, 10 or 100mg
KLH (CalBiochem, San Diego, CA) or DNP-KLH
(CalBiochem) in PBS. Each mouse was injected in three
sites—intraperitoneally (i.p.) and subcutaneously (s.c.)
between the shoulder blades and at the base of
the tail. Adults received 100ml and neonates 10ml per
site. For the experiment shown in Fig. 1, the animals were
reimmunized with DNP-KLH in PBS 2 weeks after the
initial immunization. Adults again received 100mg; the 2
week old mice originally immunized as neonates were
weighed and re-immunized with 5mg/g DNP-KLH.
Injection of CAF1 Cells into Neonates
Adult CAF1 mice were used to prepare donor cells. Red
cells were removed from spleen cell suspensions by
hypotonic lysis and mesenteric, inguinal, axillary, brachial
and cervical lymph nodes were pooled to prepare lymph
nodecellsuspensions (Adkins andDu,1998;Adkinsetal.,
2000). Preparations of spleen and lymph node cells were
mixed and washed twice with HBSS prior to injection.
One day old BALB/c neonates or adult mice were injected
with 1 £ 107 pooled spleen and lymph node cells;
neonates received a total volume of 50ml in the facial
vein, adults were injected with a total volume of 250mli n
the tail vein.
Splenectomy
Neonates and adults were splenectomized as described
previously (Adkins et al., 2001). Brieﬂy, anesthetized
animals were placed on their stomachs and a small incision
was made on the right back side, just below the rib cage.
Spleenswerepinchedoffwithforcepsandthewoundswere
closed with silk braided sutures (Ethicon, attached 5-0
needle) for neonates or with surgical staples for adults.
Skin Grafting
Using a number 11 scalpel, sections of epidermis
approximately 4mm long by 2mm wide were removed
from the tails of anesthetized donors and host animals.
Donor skin was placed on a reciprocal, prepared site on
the host tails, in reverse orientation so that hair growth was
in the opposite direction from that of the host. Slight
pressure was applied with sterile gauze to allow for initial
adherence. The tails were left in the open air for
10–15min. To protect the graft site, plastic tubes with air
holes and with inner diameters approximately twice that of
the diameter of the tails were placed over the tails. The
tubes were held in place with masking tape made into
butterﬂy shapes; the “butterﬂies” were taped to the tails
just beneath the tubes. Mice with skin grafts were housed
in cages with corncob or paper towel bedding. The tubes
were removed on day 2–3 after grafting.
Beginning on day 4, the grafts were judged for signs of
rejection. Complete rejection was deﬁned as shriveling of
the graft leading to the drying and ﬂaking away of the
graft. Graft acceptance was deﬁned as a completely healed
graft that was differentiated from the rest of the tail skin by
the reverse growth of the graft hair.
Serum ELISA for IgG1 and IgG2a Isotype
Serum samples from individual animals were analyzed
separately using IgG1 or IgG2a speciﬁc ELISA assays, as
previously described (Adkins and Du, 1998).
ELISA for Anti-nuclear Antibodies
Serum samples from different animals were analyzed
individually using an anti-nuclear antibody kit
(Alpha Diagnostic, San Antonio, TX), precisely per the
manufacturer’s instructions.
Preparation of Cells for Tissue Culture
Totalspleencellsuspensionswere preparedandRBCwere
removed by incubation in hypotonic lysis buffer (0.15M
NH4Cl, 0.001M KHCO3 and 0.1mM EDTA). Mesenteric,
B. ADKINS et al. 50inguinal, axillary, brachial and cervical lymph nodes were
pooled and used for total lymph node cell suspensions.
Enriched CD4
þ (95–98% CD4
þ) cells were positively
selected (MS
þ columns) using the Miltenyi Biotec
(Bergisch-Gladbach, Germany) MACS system, according
to the manufacturer’s directions.
For examining allogeneic responses (Figs. 2 and 5),
stimulator cells were spleen cells from C57BL/6, BALB/c
or CAF1 mice treated with 50mg/ml mitomycin C. For
stimulation of CD4
þ cells with KLH (Fig. 4), splenic APC
were prepared by treating total BALB/c spleen cells with
anti-Thy-1 (mAb 42-21) plus complement, followed by
treatment with 50mg/ml mitomycin C.
Cytokine ELISA and ELISPOT Assays
Thecultureconditionsandthemethodsforassayingcytokine
production by or cytokine secreting cells among total
lymphnodeandspleencellsinresponsetorestimulationwith
KLH have been previously described in detail (Adkins and
Du, 1998; Adkins et al., 2000; Adkins et al., 2001).
For the experiments analyzing cytokine production by
alloantigen speciﬁc memorycells (Fig. 2), totallymph node
cellsfromindividualanimalswereculturedseparately.2:5 £
105 lymphnoderespondersand5:0 £ 105 splenicstimulator
cells were cultured in 200ml of medium per well in 96 well
plates. For the experiments analyzing primary responses of
fractionated cells (Figs. 4–6), CD4
þ cells were cultured at
2.0 £ 10
5 cells per well. 5.0 £ 10
5 CAF1 or C57BL/6
splenic stimulator cells were used for the alloantigen
stimulation (Figs. 5 and 6) or 5.0 £ 10
5 BALB/c splenic
APC were used for restimulation with 50mg/ml KLH
(Fig. 4).
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